Page last updated: 2024-08-21

erythromycin and sirolimus

erythromycin has been researched along with sirolimus in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (12.50)18.2507
2000's10 (62.50)29.6817
2010's3 (18.75)24.3611
2020's1 (6.25)2.80

Authors

AuthorsStudies
Beck, WT; Schuetz, EG; Schuetz, JD1
Li, Y; Li, YH; Wang, YH; Yang, L; Yang, SL1
Andricopulo, AD; Moda, TL; Montanari, CA1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Cane, DE; Fu, H; Khosla, C; Lau, J1
Dhingra, N; Kaur, H; Khanna, R; Kumari, R; Lal, R; Tuteja, D1
Brattström, C; Burke, JT; Claesson, K1
Hayakawa, A; Itaya, N; Kakegawa, T; Kobayashi, H; Saito, H1
De Vos, M; Depoortere, I; Lefebvre, R; Peeters, TL; Schoonjans, R; Van Vlem, B; Vanholder, R1
Kealey, JT1
Akagawa, K; Omura, S; Osawa, T; Sunatsuka, T1
Beyer, D; Bizot, MN; Jiang, Q; Kovarik, JM; Schmouder, RL; Shenouda, M1
Akagawa, K; Omura, T; Osawa, M; Sawai, T; Sunazuka, T1
Chasick, A; Chasik, A; Hughes, T; Leiding, JW; Salit, RB1
Grininger, M1

Reviews

4 review(s) available for erythromycin and sirolimus

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Regulation and manipulation of the gene clusters encoding type-I PKSs.
    Trends in biotechnology, 2000, Volume: 18, Issue:6

    Topics: Combinatorial Chemistry Techniques; Erythromycin; Gene Expression Regulation; Genetic Engineering; Multienzyme Complexes; Multigene Family; Rifamycins; Sirolimus

2000
Creating polyketide diversity through genetic engineering.
    Frontiers in bioscience : a journal and virtual library, 2003, Jan-01, Volume: 8

    Topics: Carbohydrate Sequence; Epothilones; Erythromycin; Molecular Structure; Multienzyme Complexes; Peptides; Protein Engineering; Ribosomal Proteins; Sirolimus

2003
Enzymology of assembly line synthesis by modular polyketide synthases.
    Nature chemical biology, 2023, Volume: 19, Issue:4

    Topics: Anti-Bacterial Agents; Erythromycin; Polyketide Synthases; Polyketides; Sirolimus

2023

Trials

1 trial(s) available for erythromycin and sirolimus

ArticleYear
Effect of multiple-dose erythromycin on everolimus pharmacokinetics.
    European journal of clinical pharmacology, 2005, Volume: 61, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Area Under Curve; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Erythromycin; Everolimus; Female; Half-Life; Humans; Immunosuppressive Agents; Male; Sirolimus

2005

Other Studies

11 other study(ies) available for erythromycin and sirolimus

ArticleYear
Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells.
    Molecular pharmacology, 1996, Volume: 49, Issue:2

    Topics: Adenocarcinoma; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Blotting, Northern; Cell Line; Clotrimazole; Colonic Neoplasms; Cytochrome P-450 CYP2E1; Cytochrome P-450 Enzyme System; Dexamethasone; DNA Primers; Doxorubicin; Gene Expression Regulation, Neoplastic; Humans; Midazolam; Mixed Function Oxygenases; Molecular Sequence Data; Multigene Family; Phenobarbital; Phenytoin; Polymerase Chain Reaction; Rifampin; Tumor Cells, Cultured; Verapamil

1996
Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism.
    Bioorganic & medicinal chemistry letters, 2005, Sep-15, Volume: 15, Issue:18

    Topics: Computational Biology; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Molecular Structure; Principal Component Analysis; Pyrrolizidine Alkaloids; Quantitative Structure-Activity Relationship; Reproducibility of Results; Substrate Specificity; Venlafaxine Hydrochloride

2005
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Dissecting the role of acyltransferase domains of modular polyketide synthases in the choice and stereochemical fate of extender units.
    Biochemistry, 1999, Feb-02, Volume: 38, Issue:5

    Topics: Acyl Coenzyme A; Acyltransferases; Amino Acid Sequence; Erythromycin; Escherichia coli; Isoenzymes; Molecular Sequence Data; Multienzyme Complexes; Plasmids; Protein Processing, Post-Translational; Protein Structure, Tertiary; Recombinant Fusion Proteins; Sirolimus; Stereoisomerism; Streptomyces; Substrate Specificity; Thiolester Hydrolases

1999
Sirolimus and erythromycin interaction: two cases.
    Transplantation proceedings, 2001, Volume: 33, Issue:3

    Topics: Adult; Aged; Anti-Bacterial Agents; Erythromycin; Humans; Immunosuppressive Agents; Kidney Transplantation; Legionellosis; Male; Postoperative Complications; Sirolimus

2001
[Effect of rapamycin on cytoplasmic accumulation of hetero nuclear ribonucleoprotein C-like unwinding protein 2].
    The Japanese journal of antibiotics, 2001, Volume: 54 Suppl A

    Topics: Animals; Anti-Bacterial Agents; Cells, Cultured; Cytoplasm; Erythromycin; Heterogeneous-Nuclear Ribonucleoproteins; Immunosuppressive Agents; Mice; NF-kappa B; Ribonucleoproteins; Roxithromycin; Sirolimus; Tacrolimus

2001
In vitro evaluation of motilin agonism by macrolide immunosuppressive drugs.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2002, Volume: 17, Issue:6

    Topics: Animals; Carbachol; Cyclosporine; Duodenum; Electric Stimulation; Erythromycin; Immunosuppressive Agents; In Vitro Techniques; Kinetics; Male; Motilin; Muscle Contraction; Muscle, Smooth; Rabbits; Sirolimus; Tacrolimus

2002
[Influence of erythromycin and the metabolite, EM201 on IL-2 receptor signaling].
    The Japanese journal of antibiotics, 2003, Volume: 56 Suppl A

    Topics: Anti-Bacterial Agents; Cell Division; Cells, Cultured; Depression, Chemical; Erythromycin; Humans; Lymphocyte Activation; Receptors, Interleukin-2; Signal Transduction; Sirolimus; T-Lymphocytes

2003
[Effect of EM201, an in vivo metabolite of erythromycin (EM), on signal transduction of IL-2 receptor].
    The Japanese journal of antibiotics, 2004, Volume: 57 Suppl A

    Topics: Cells, Cultured; Chromones; Erythromycin; Flavonoids; Humans; Monocytes; Morpholines; Receptors, Interleukin-2; Signal Transduction; Sirolimus

2004
Successful sirolimus graded dose challenge in an erythromycin-allergic patient.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2012, Volume: 109, Issue:4

    Topics: Adult; Drug Administration Schedule; Erythromycin; Feasibility Studies; Hematopoietic Stem Cell Transplantation; Human T-lymphotropic virus 1; Humans; Leukemia-Lymphoma, Adult T-Cell; Recurrence; Sirolimus

2012